Accretion Nutraveda Ltd vs Ishita Drugs Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Accretion Nutraveda Ltd is ₹ 253.5 as of 05 May 15:30 . The P/E Ratio of Accretion Nutraveda Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Ishita Drugs & Industries Ltd changed from 10.8 on March 2021 to 27.1 on March 2025 . This represents a CAGR of 20.20% over 5 years The Market Cap of Accretion Nutraveda Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Ishita Drugs & Industries Ltd changed from ₹ 8.97 crore on March 2021 to ₹ 23.48 crore on March 2025 . This represents a CAGR of 21.22% over 5 years The revenue of Accretion Nutraveda Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Ishita Drugs & Industries Ltd for the Dec '25 is ₹ 3.23 crore as compare to the Sep '25 revenue of ₹ 3.14 crore. This represent the growth of 2.87% The ebitda of Accretion Nutraveda Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Ishita Drugs & Industries Ltd for the Dec '25 is ₹ 0.24 crore as compare to the Sep '25 ebitda of ₹ 0.25 crore. This represent the decline of -4% The net profit of Accretion Nutraveda Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Ishita Drugs & Industries Ltd changed from ₹ 0.15 crore to ₹ 0.16 crore over 7 quarters. This represents a CAGR of 3.76% The Dividend Payout of Accretion Nutraveda Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Ishita Drugs & Industries Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Accretion Nutraveda Ltd

Accretion Nutraveda Limited was initially incorporated as a Private Limited Company on March 16, 2021 and has subsequently, converted the status into a Public Limited Company vide Certificate of Incorporation issued by the Registrar of Companies, Central Processing Centre w.e.f.
May 2, 2025. The Company, established at Ahmedabad, is a healthcare-focused Contract Development and Manufacturing Organization (CDMO), offering specialized services to a diverse range of clients across the various industries.
It specialize in ayurvedic and nutraceutical products including Tablets, Capsules, Oral Liquids, Oral Powders, External Preparation and Oils.
Apart from these, it offer a diverse range of dosage forms, leveraging both Classical Ayurvedic principles and modern nutraceutical science. The products include Tablets, such as film-coated and chewable varieties, for applications in liver care, gynecological care, bone and joint health, and respiratory support.

About Ishita Drugs & Industries Ltd

Ishita Drugs & Industries Limited was incorporated in February, 1992 by Jagdish Agarwal.
The Company is engaged in the manufacture of various Activa Pharma Ingredients, drug intermediates, fine chemicals and excipient.
The company supplies its products to leading pharmaceutical companies of India.
The products are also being exported to various countries across the world.
The plant has been designed and constructed to meet GMP norms. The genesis of the Ishita Group in 1992 was the result of the entrepreneurial spirit of Mr. Jagdish Agrawal, who set up a reactive dye manufacturing unit in Ahmedabad.

FAQs for the comparison of Accretion Nutraveda Ltd and Ishita Drugs & Industries Ltd

Which company has a larger market capitalization, Accretion Nutraveda Ltd or Ishita Drugs & Industries Ltd?

Market cap of Accretion Nutraveda Ltd is 183 Cr while Market cap of Ishita Drugs & Industries Ltd is 23 Cr

What are the key factors driving the stock performance of Accretion Nutraveda Ltd and Ishita Drugs & Industries Ltd?

The stock performance of Accretion Nutraveda Ltd and Ishita Drugs & Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Accretion Nutraveda Ltd and Ishita Drugs & Industries Ltd?

As of May 5, 2026, the Accretion Nutraveda Ltd stock price is INR ₹253.5. On the other hand, Ishita Drugs & Industries Ltd stock price is INR ₹78.61.

How do dividend payouts of Accretion Nutraveda Ltd and Ishita Drugs & Industries Ltd compare?

To compare the dividend payouts of Accretion Nutraveda Ltd and Ishita Drugs & Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.